|
DNAJA1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.400960E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.682800E-03 |
| Normal-vs-Stage2 |
9.588600E-04 |
| Normal-vs-Stage3 |
3.572100E-04 |
| Normal-vs-Stage4 |
3.353200E-04 |
| Stage1-vs-Stage2 |
1.087950E-01 |
| Stage1-vs-Stage3 |
9.202400E-03 |
| Stage1-vs-Stage4 |
2.583600E-02 |
| Stage2-vs-Stage3 |
7.906000E-01 |
| Stage2-vs-Stage4 |
6.641800E-01 |
| Stage3-vs-Stage4 |
8.036400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.156000E-03 |
| Normal-vs-AfricanAmerican |
1.760040E-03 |
| Normal-vs-Asian |
2.568000E-02 |
| Caucasian-vs-AfricanAmerican |
5.304200E-01 |
| Caucasian-vs-Asian |
1.430560E-01 |
| AfricanAmerican-vs-Asian |
1.823210E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.038500E-04 |
| Normal-vs-Female |
2.644800E-03 |
| Male-vs-Female |
1.566190E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.024500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.460600E-03 |
| Normal-vs-Age(61-80Yrs) |
5.92419999999594E-05 |
| Normal-vs-Age(81-100Yrs) |
1.096170E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.900100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.28330000001864E-06 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.412800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.235900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.058600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.816200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.271870E-02 |
| Classical-VS-Follicular |
1.50339996007887E-09 |
| Classical-VS-Other |
4.485800E-01 |
| Classical-VS-Normal |
8.043800E-03 |
| Tall-VS-Follicular |
1.194770E-01 |
| Tall-VS-Other |
9.579200E-01 |
| Tall-VS-Normal |
2.808200E-04 |
| Follicular-VS-Other |
4.556200E-01 |
| Follicular-VS-Normal |
1.74885999999486E-05 |
| Other-VS-Normal |
1.337250E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.797400E-04 |
| Normal-vs-N1 |
4.006900E-04 |
| N0-vs-N1 |
3.764400E-01 |
|
|
